• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Neurohormonal activation and diagnostic value of cardiac peptides in patients with suspected mild heart failure.

作者信息

Mikkelsen Kirsten V, Bie Peter, Møller Jacob E, Videbaek Lars, Villadsen Henrik D, Haghfelt Torben

机构信息

Department of Cardiology, Odense University Hospital, Odense, Denmark.

出版信息

Int J Cardiol. 2006 Jun 28;110(3):324-33. doi: 10.1016/j.ijcard.2005.08.003. Epub 2005 Oct 6.

DOI:10.1016/j.ijcard.2005.08.003
PMID:16213609
Abstract

BACKGROUND

Data describing activation of brain natriuretic peptide (BNP) system relative to the renin-angiotensin-aldosterone system (RAAS) are sparse in the early phase of heart failure (HF).

AIMS

To compare activation of BNP system relative to RAAS hyperactivity and to assess diagnostic accuracy of cardiac peptides to detect any left ventricular dysfunction (LVD) in patients referred from primary care with suspected HF before institution of medical therapy.

METHODS

Of 166 referred patients 150 were consecutively included (14 were excluded and two refused consent). Echocardiography and measurements of neurohormonal activity were performed. Systolic dysfunction (LVSD) was defined as an ejection fraction<or=0.45. Abnormal left ventricular filling was determined by a combination of Doppler techniques.

RESULTS

LVSD with concomitant abnormal left ventricular filling was present in 22 patients, and abnormalities in left ventricular filling alone were present in 58. Median BNP were 307 and 37 pg/ml while median N-terminal proBNP (NT-proBNP) were 2285 and 199 pg/ml in the two groups respectively, and were significantly lower in patients without LVD (BNP: 8 pg/ml and NT-proBNP: 55 pg/ml, P<0.0001). NT-proBNP demonstrated a weak negative correlation with renin (r=-0.18, P=0.03) and aldosterone (r=-0.18, P=0.03), but no significant correlation with Ang II (r=-0.14, P=0.10) or noradrenaline (r=0.11, P=0.19). Renin correlated well with Ang II (r=0.85, P<0.0001), and aldosterone (r=0.41, P<0.0001). RAAS and noradrenaline demonstrated no diagnostic potential for the diagnosis of any LVD with areas under ROC curves close to 0.50. The area was 0.93 (95% CI 0.90-0.98) for BNP and 0.95 (0.91-0.99) for NT-proBNP. In 5-10% of patients with LVD, BNP and NT-proBNP were under the selected thresholds.

CONCLUSION

Patients with LVD demonstrated considerable activation of the BNP system, whereas RAAS hyperactivity could not be demonstrated. Thus, BNP and NT-proBNP had a considerable diagnostic potential even in patients with mild HF.

摘要

相似文献

1
Neurohormonal activation and diagnostic value of cardiac peptides in patients with suspected mild heart failure.
Int J Cardiol. 2006 Jun 28;110(3):324-33. doi: 10.1016/j.ijcard.2005.08.003. Epub 2005 Oct 6.
2
Diagnostic accuracy of plasma brain natriuretic peptide and aminoterminal-proBNP in mild heart failure depends on assay and introduction of therapy.血浆脑钠肽和氨基末端脑钠肽前体在轻度心力衰竭中的诊断准确性取决于检测方法和治疗的引入。
Scand J Clin Lab Invest. 2005;65(8):633-47. doi: 10.1080/00365510500333577.
3
Comparative value of BNP and NT-proBNP in diagnosis of heart failure.BNP与NT-proBNP在心力衰竭诊断中的比较价值
Rev Port Cardiol. 2004 Jul-Aug;23(7-8):979-91.
4
Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.血浆脑钠肽在鉴别充血性心力衰竭患者与其他疾病中的作用。
J Med Assoc Thai. 2003 May;86 Suppl 1:S87-95.
5
Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.N端前B型利钠肽与B型利钠肽在有/无左心室收缩功能障碍患者中的头对头比较。
Clin Biochem. 2006 Jun;39(6):640-5. doi: 10.1016/j.clinbiochem.2006.01.021. Epub 2006 Mar 3.
6
NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies.N末端脑钠肽前体(NT-proBNP)与心力衰竭的诊断:三项欧洲流行病学研究的汇总分析
Eur J Heart Fail. 2004 Mar 15;6(3):269-73. doi: 10.1016/j.ejheart.2004.01.010.
7
Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.N 末端前脑钠肽和脑钠肽在预测左心室射血分数保留的心力衰竭患者心血管结局中的应用价值。
Am J Cardiol. 2008 Sep 15;102(6):733-7. doi: 10.1016/j.amjcard.2008.04.048. Epub 2008 Jul 9.
8
Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.N末端B型利钠肽原(NT-proBNP)对慢性肾脏病5期血液透析患者左心室功能障碍的诊断价值
Nephrol Dial Transplant. 2008 Apr;23(4):1370-7. doi: 10.1093/ndt/gfm700. Epub 2007 Dec 18.
9
[Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].[脑钠肽及N末端脑钠肽原在先天性心脏病患儿心功能评估中的价值]
Zhongguo Dang Dai Er Ke Za Zhi. 2009 Jun;11(6):429-32.
10
Head-to-head comparison of BNP and IL-6 as markers of clinical and experimental heart failure: Superiority of BNP.脑钠肽(BNP)与白细胞介素-6(IL-6)作为临床及实验性心力衰竭标志物的直接比较:BNP的优势
Cytokine. 2007 Nov;40(2):89-97. doi: 10.1016/j.cyto.2007.08.009. Epub 2007 Oct 24.

引用本文的文献

1
Performance of BNP and NT-proBNP for diagnosis of heart failure in primary care patients: a systematic review.B型利钠肽(BNP)和N末端B型利钠肽原(NT-proBNP)在基层医疗患者心力衰竭诊断中的性能:一项系统评价
Heart Fail Rev. 2014 Aug;19(4):439-51. doi: 10.1007/s10741-014-9445-8.
2
Guidelines for the management of adult lower respiratory tract infections--full version.成人下呼吸道感染管理指南——全文版。
Clin Microbiol Infect. 2011 Nov;17 Suppl 6(Suppl 6):E1-59. doi: 10.1111/j.1469-0691.2011.03672.x.
3
Sensitivity and specificity of NT-proBNP to detect heart failure at post mortem examination.
NT-proBNP 对死后检查心力衰竭的敏感性和特异性。
Int J Legal Med. 2011 Nov;125(6):849-56. doi: 10.1007/s00414-011-0581-6. Epub 2011 May 20.